A carregar...
Sorafenib for the Treatment of Hepatocellular Carcinoma: A Systematic Review
BACKGROUND: Sorafenib, a drug that inhibits Raf serine/threonine kinases mediating cell proliferation and receptor tyrosine kinases involved in angiogenesis, is approved for the treatment of advanced hepatocellular carcinoma (HCC). AIMS: To explore the efficacy and safety of sorafenib for treating a...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3596114/ https://ncbi.nlm.nih.gov/pubmed/22451120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-012-2136-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|